Browse Drug Recalls
18,008 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 18,008 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 18,008 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 28, 2023 | diphenhydrAMINE 50 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial A... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | NORepinephrine added to 0.9% sodium chloride, 8 mg/250 mL* (32 mcg/mL), 250 m... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Induction 8:1 non-enriched, HIGH POTASSIUM, 70 mEq K, ... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2%/Dextrose 10% with low c... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Maintenance 4:1 low potassium/low tromethamine, 36 mEq... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 2.5%/Dextrose 10% with CAL... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 6%/Dextrose 10% with low c... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | vancomycin added to 0.9% sodium chloride, 1.5 g/250 mL* (6 mg/mL), 250 mL per... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Modified St Thomas Formula, low potassium, 70 mEq K, p... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | potassium phosphate 30 mmole added to 0.9% sodium chloride 500 mL per bag, Rx... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Modified St Thomas Solution, HIGH POTASSIUM, HIGH SODI... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCI... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | NORepinephrine added to dextrose 5%, 16 mg/250 mL* (64 mcg/mL), 250 mL per ba... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Maintenance 8:1 low potassium, 24 mEq K, packaged in 5... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | EPINEPHrine added to dextrose 5%, 2 mg/250 mL* (8 mcg/mL), 250 mL per bag, Rx... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | EPINEPHrine added to dextrose 5%, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, R... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | oxyTOCIN 20 units added to dextrose 5%/Lactated Ringer's 1,000 mL per bag, Rx... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Induction 4:1 High Potassium, 30 mEq K, packaged in 41... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Induction 4:1, High Potassium, 60 mEq K, packaged in 8... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4.5%/Dextrose 10% with HEP... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | norepinephrine 4 mg added to dextrose 5% 250 mL*, 16 mcg/mL, 250 mL per bag, ... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | HyperLyte CR Injection, 500 mL bag, Rx only, Central Admixture Pharmacy Serv... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | heparin added to 0.9% sodium chloride, 2,500 units/500 mL* (5 units/mL), 500 ... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with low ca... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Reperfusate No Potassium, packaged in 477.5 mL per bag... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | oxyTOCIN 40 units added to 0.9% sodium chloride 1,000 bag, Rx only, Central A... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Induction 4:1 in Ringer's, HIGH POTASSIUM, 48 mEq K, p... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Cardioplegia Solution, Maintenance 4:1 in Ringer's, low potassium, 12 mEq K, ... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | EPINEPHrine added to 0.9% sodium chloride, 4 mg/250 mL* (16 mcg/mL), 250 mL p... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10% with CALCI... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | vancomycin added to 0.9% sodium chloride, 1 g/250 mL* (4 mg/mL), 25 250 mL pe... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | HyperLyte CR Injection, 250 mL bag, Rx only, Central Admixture Pharmacy Servi... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | heparin added to 0.9% sodium chloride, 2,500 units/250 mL* (10 units/mL), 250... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | vasopressin 40 units added to 0.9% sodium chloride 100 mL*, 0.4 units/mL*, 10... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Transplant Solution (Plasma-Lyte A), packaged in 165 mL per bag, Rx only, Cen... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 28, 2023 | Microplegia Solution, MSA/MSG 0.92 Molar with CP2D, packaged in 120 mL per ba... | Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the... | Class II | Central Admixture Pharmacy Services, Inc. |
| Apr 27, 2023 | Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets... | Labeling: Incorrect or Missing Package Insert | Class III | Teva Pharmaceuticals USA Inc |
| Apr 27, 2023 | Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets... | Labeling: Incorrect or Missing Package Insert | Class III | Teva Pharmaceuticals USA Inc |
| Apr 27, 2023 | Fentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets... | Labeling: Incorrect or Missing Package Insert | Class III | Teva Pharmaceuticals USA Inc |
| Apr 27, 2023 | Fentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets... | Labeling: Incorrect or Missing Package Insert | Class III | Teva Pharmaceuticals USA Inc |
| Apr 27, 2023 | Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets... | Labeling: Incorrect or Missing Package Insert | Class III | Teva Pharmaceuticals USA Inc |
| Apr 26, 2023 | Rifampin Capsules USP, 150 mg, 30-count bottles, Rx Only, Sterile, Distribute... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Neomycin & Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment, 3.5... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Tropicamide Ophthalmic Solution, USP 0.5%, 15 mL bottles, Rx only, Distribute... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Fluticasone Propionate Nasal Spray, 50mcg, 16 g bottles, Manufactured by: HI-... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Trihexyphenidyl Hydrochloride Oral Solution, USP, 2mg/5mL, 473 mL bottles, R... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Sterile, packaged in a) 3mL... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL bottles, Rx Only, Dis... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
| Apr 26, 2023 | Sufenta (Sufentanil Citrate Injection, USP) 50 mcg/mL, packaged in a)1 mL amp... | CGMP Deviations: Firm went out of business and could no longer continue stability studies. | Class II | Akorn, Inc. |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.